CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

This small-cap stock gains by more than 30 per cent in just two days
DSIJ Intelligence
/ Categories: Trending, DSIJ News

This small-cap stock gains by more than 30 per cent in just two days

The shares of Thyrocare Technologies have gained by almost 31.45 per cent in just two trading sessions. The stock has been buzzing since the second day of this week when it jumped by 14.10 per cent during Tuesday’s trading session.

The company announced that for Q2FY21, it has witnessed very positive growth and increased turnover of COVID PCR and COVID antibody testing with the revenue for Q2FY21 increasing by about 37 per cent compared to that in Q2FY20. Also, the company reported a huge surge in the revenue for Q2FY21 by 171 per cent thus, bouncing back from the low revenue posted for Q1FY21.

On Wednesday, the shares of Thyrocare Technologies made a fresh 52-week high of Rs 1,038.60 per share. The stock continues to gain from the pharma sector’s upward trend.

While the scrip gained by 35.07 per cent in a month, it has doubled by gaining around 101.79 per cent in the last one year.

Currently, the stock of the company is trading at Rs 1,011.15, up by 14.36 per cent or Rs 126.95 per share. It is one of the top gainers in BSE Small-Cap index.

Previous Article Reliance surges on ADIA investment in RIL retail arm
Next Article Glenmark Pharma gets USFDA nod for multiple sclerosis drugs
Print
2494 Rate this article:
4.1
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR